Showing results (1-10 of 102) with videos related to
Sort By:
Pageof 11
Best Practice & Research. Clinical Rheumatology|December 19, 2019
Autoantibodies in connective tissue diseaseBen Mulhearn, Sarah L Tansley, Neil J McHughFrontiers in Immunology|February 14, 2022
A Commercial Anti-TIF1γ ELISA Is Superior to Line and Dot Blot and Should Be Considered as Part of Routine Myositis-Specific Antibody TestingBen Mulhearn, Danyang Li, Fionnuala McMorrow, et al.Expert Review of Clinical Immunology|December 15, 2015
Serological subsets of juvenile idiopathic inflammatory myopathies--an updateSarah L Tansley, Neil J McHughCurrent Rheumatology Reports|December 4, 2014
Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathiesSarah L Tansley, Neil J McHughClinical Rheumatology|August 25, 2015
The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic reviewErin Vermaak, Sarah L Tansley, Neil J McHughCurrent Opinion in Rheumatology|September 20, 2013
The diagnostic utility of autoantibodies in adult and juvenile myositisSarah L Tansley, Zoe E Betteridge, Neil J McHughArthritis Research & Therapy|April 10, 2013
Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms?Sarah L Tansley, Neil J McHugh, Lucy R WedderburnRheumatology (Oxford, England)|February 8, 2020
The reliability of immunoassays to detect autoantibodies in patients with myositis is dependent on autoantibody specificitySarah L Tansley, Danyang Li, Zoe E Betteridge, et al.Rheumatology (Oxford, England)|July 3, 2014
Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onsetSarah L Tansley, Zoe E Betteridge, Gavin Shaddick, et al.Pageof 11